Differential DNA-binding and cofactor recruitment are possible determinants of the synthetic steroid YK11-dependent gene expression by androgen receptor in breast cancer MDA-MB 453 cells

Exp Cell Res. 2022 Oct 15;419(2):113333. doi: 10.1016/j.yexcr.2022.113333. Epub 2022 Aug 27.

Abstract

Recently, selective androgen receptor modulators (SARMs), which bind to AR and act in a tissue/effect-specific manner, have been developed, but the selective mechanism is not well understood. In this study, we investigated the selective mechanism using the synthetic steroid YK11, which showed AR-mediated gene-selective transactivation. In the AR-positive human breast cancer MDA-MB-453 cells, different patterns of AR-mediated target gene expression and AR recruitment to their enhancer regions were observed between DHT and YK11. A docking study suggested the helices 11 and 12 was moved by the sterically hindered C17-group of YK11. Furthermore, the mutational studies of AR Gln902 and mammalian two-hybrid assays suggested different cofactor recruitment between DHT and YK11. The results of this study suggest that gene selective regulation by SARMs results from differential DNA-binding and/or cofactor recruitment by ligands. These results provide novel insights into the mechanism of action of SARMs.

Keywords: Androgen receptor; Breast cancer; Nuclear receptor; Selective androgen receptor modulator.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androgens / pharmacology
  • Animals
  • Breast Neoplasms* / genetics
  • DNA
  • Female
  • Gene Expression
  • Humans
  • Mammals / genetics
  • Receptors, Androgen* / genetics
  • Receptors, Androgen* / metabolism
  • Steroids

Substances

  • Androgens
  • Receptors, Androgen
  • Steroids
  • DNA